Urovant Sciences Ltd (UROV)

Urovant Sciences to Present Interim Data from Phase 2a Study of Potential Novel Gene Therapy, URO-902, and New Analyses of Data from Phase 3 EMPOWUR Extension Trial of GEMTESA® (vibegron) 75 mg at 2022 American Urological Association Annual Meeting

Urovant Sciences Announces Publication in Advances in Therapy of Analyses of Patient-Perceived Meaningfulness of Improvement in Symptom Reduction for Overactive Bladder Patients Treated with GEMTESA® (vibegron) 75 mg

Urovant Sciences Announces Publication in Blood Pressure Monitoring of Positive Ambulatory Blood Pressure Study Results for GEMTESA® (vibegron) 75 mg in Overactive Bladder Patients

Urovant Sciences Provides Merger Update and Reports Third Quarter Fiscal Year 2020 Results

Urovant Sciences Announces Progression of URO-902 Phase 2a Trial Following Positive Recommendation from the Data and Safety Monitoring Board

INVESTIGATION ALERT: Halper Sadeh LLP Investigates MDCA, NHLD, COHR, UROV; Shareholders Are Encouraged to Contact the Firm

Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders Are Encouraged to Contact the Firm - CPAH, UROV, ANH, CGIX, CBLI, NEOS

SHAREHOLDER ALERT: WeissLaw LLP Reminds JWS, BRPA, and UROV Shareholders About Its Ongoing Investigations

SHAREHOLDER ALERT: Halper Sadeh LLP Investigates UROV, WTRE, CBMG, NAV; Shareholders Are Encouraged to Contact the Firm

Lifshitz Law Firm, P.C. Announces Investigation of CBMG, CIT, HMSY, INFO, PS, SPWH, UROV, and WDR

INVESTIGATION ALERT: Halper Sadeh LLP Investigates COHR, CBMG, WTRE, NAV, UROV; Shareholders Are Encouraged to Contact the Firm

ALERT: Halper Sadeh LLP Reminds Investors of Its Ongoing Merger Investigations; Shareholders are Encouraged to Contact the Firm – CBMG, CGIX, UROV

SHAREHOLDER ALERT: Monteverde & Associates Continues to Investigate the Following Merger

INVESTIGATION ALERT: Halper Sadeh LLP Investigates FFG, NHLD, HCAP, NAV, UROV; Shareholders Are Encouraged to Contact the Firm

Lifshitz Law Firm, P.C. Announces Investigation of CIT, CPAH, INFO, MTSC, NAV, STND, UROV, and WTRE

MERGER INVESTIGATION: Halper Sadeh LLP Investigates CBMG, ALSK, UROV, NAV; Shareholders Are Encouraged to Contact the Firm

ALERT: Halper Sadeh LLP Investigates WTRE, CIT, ALSK, NAV, UROV; Shareholders Are Encouraged to Contact the Firm

Lifshitz Law Firm, P.C. Announces Investigation of CBMG, CBLI, WORK, and UROV

NEW YORK, NY / ACCESSWIRE / January 3, 2021 / Lifshitz Law Firm, P.C.: Cellular Biomedicine Group, Inc. (NASDAQ:CBMG) Lifshitz Law Firm, P.C. announces investigation into possible breach of fiduciary duties in connection with the sale of CBMG to members of CBMG management. If you are a CBMG investor, and would like additional information about our investigation, please complete the Information Request Form or contact Joshua

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Mergers – UROV, EIGI, SNCA, CLCT

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of UROV, SNSS, TCF, and PS Mergers

SHAREHOLDER ALERT: WeissLaw LLP Reminds UROV, WTRE, EIGI, and TNAV Shareholders About Its Ongoing Investigations

SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Companies -UROV, INFO, WDR, CKH, EIGI

Urovant Sciences Announces U.S. FDA Approval of GEMTESA® (vibegron) 75 mg Tablets for the Treatment of Patients with Overactive Bladder (OAB)

SHAREHOLDER ALERT: Halper Sadeh LLP Investigates the Following Companies – WDR, WORK, INFO, UROV

Lifshitz Law Firm, P.C. Announces Investigation of ANH, RC, CPAH, GIK, MTSC, WORK, CRM, TGC, UROV, and WDR

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies - CKH, HBAN, PS, UROV, XLNX

SHAREHOLDER ALERT: WeissLaw LLP Reminds SFBK, ACAM, CBLI, and UROV Shareholders About Its Ongoing Investigations

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of WDR, CLCT, NAV, and UROV Buyouts

SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following Companies – EIGI, XLNX, UROV, HDS

INVESTIGATION ALERT: Halper Sadeh LLP Continues to Investigate the Following Companies; Shareholders are Encouraged to Contact the Firm - EIGI, CKH, UROV, PNM, INFO

WeissLaw LLP Reminds UROV, NAV, PNM, and MVC Shareholders About Its Ongoing Investigations

INVESTIGATION ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm – CKH, EIGI, HDS, UROV

INVESTIGATION ALERT: Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm - WORK, WDR, BBIO, UROV, HDS

UROVANT SCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Urovant Sciences - UROV

Halper Sadeh LLP Reminds Shareholders About Its Ongoing Merger Investigations; Investors are Encouraged to Contact the Firm – NAV, UROV, HDS, AKER

SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of NAV, UROV, AKER, and EMIS Mergers